ArcScan Announces New, Reimbursable Glaucoma Imaging Capabilities of Insight 100®

Patients who are still phakic, but don’t seem to be currently at risk for angle closure, can be objectively measured with the Insight 100 rather than just by gonioscopy to see if the angle is actually changing and how quickly.

ArcScan, Inc., developer of state-of-the-art ophthalmic visualization technology, announced positive results of its study using existing reimbursement codes for glaucoma imaging with the Insight 100®, ArcScan’s FDA 510(k)-cleared precision point-and-shoot ultrasound device for imaging and biometry of the eye. Indicated for refractive surgical planning and evaluation of anterior segment pathology, the Insight 100 images and measures anterior chamber depth, angle-to-angle width, individual corneal layers, sulcus-to-sulcus width, anterior and posterior capsular surfaces, angles, and more—with micron level precision and repeatability, all in a patient-friendly device.

The Insight 100 generates a comprehensive glaucoma report (Figure 1) with 24 relevant data points an ophthalmologist needs to manage a glaucoma patient, whether diagnosed or just a suspect, including the degree of angle closure. The glaucoma report is generated automatically after an anterior segment scan has been completed, much in the same way an epithelium map and keratoconus report is auto-generated by the Insight 100 after a cornea scan is completed.

Zachary Vest, MD, a glaucoma specialist at Mile High Eye Institute in Englewood, CO, just completed a small study of 3 patients to determine if existing reimbursement codes could be used to bill for the scans using the Insight 100 for evaluation of glaucoma suspects. These patients were referred to Dr. Vest because each of their conditions can be a cause of increased intraocular pressure with…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *